CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Diseases of the Cardiovascular System
What is the purpose of this trial?
To demonstrate the proof of principle and initial clinical safety of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve) and increase the efficiency of the device development process by identifying appropriate modifications to the implant procedure or the device.
- Ages1 year - 70 years
- Trial withCorMatrix Cardiovascular, Inc.
- Start Date02/04/2021
- End Date12/31/2020
- Last Updated04/08/2022
- Study HIC#2000028726